DataMEDS AI MEDS 深 沪
等待开盘 09-01 09:30:00 美东时间
0.963
+0.002
+0.25%
华盛通- 最 高1.05
- 今 开0.878
- 成交量 783.16万股
- 最 低 0.8225
- 昨 收 0.9606
- 总市值 294.86万
- 52周最高 2228.00
- 市盈率 静 --
- 换手率 255.77%
- 52周最低 0.8225
- 委 比 99.12%
- 总股本 306.19万
- 历史最高 2228.00
- 量 比 11.94
- 振 幅 23.68%
- 历史最低 0.8225
- 每 手 1
- 风险率 0.91%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多DataMEDS AI reports Q2 results
DataMEDS AI press release (MEDS): Q2 Net loss per share was $7.13 Revenue was $1.779M in Q2 2026, up 14% sequentially from Q1 2026 and above management projections. More on Wellgistics Health Wellgist...
08-19 15:33
DataMEDS AI Q2 EPS $(7.13) Down From $(5.40) YoY, Sales $1.780M Down From $7.791M YoY
DataMEDS AI (NASDAQ:MEDS) reported quarterly losses of $(7.13) per share. This is a 32.04 percent decrease over losses of $(5.40) per share from the same period last year. The company reported $1.780 million in sales this quarter. This is a 77.15 percent decrease over sales of $7.791 million the sam...
08-17 21:05
DataMeds AI Reports Pharmacy Unit Corexa Health July Sales Of $600K+ With Annual Run Rate $7M+; Corexa Completes Registration With TrumpRx To Offer Patients Access To Oral GLP-1 Agonist Drugs
DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx™ combined with blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solu...
08-12 19:44
Wellgistics Health Signs Transformative Strategic Acquisition Agreement
An announcement from Wellgistics Health Inc ( ($WGRX) ) is now available. On Ju...
08-05 05:38
DataMeds AI, Datavault AI Amend Definitive Agreement To Expand PharmacyChain Blockchain-Related Technology Licensing Relationship Beyond Pharmaceutical Distribution
DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMEDS"), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to provide integrated solutions for the generation, rationalization, intervention, transaction and monetization ...
07-29 22:17
Trxade Group’s Strategic Merger and Rebranding as Scienture Holdings
Trxade Group (MEDS) has issued an announcement. On July 25, 2024, TRxADE HEALTH...
2024-08-01 05:51
Trxade Health acquires Scienture in all-stock transaction valued at $103M
TRxADE HEALTH (NASDAQ:MEDS) and Scienture has announced the closing of TRxADE’s business combination with Scienture in an all-stock transaction. TRxADE acquired all of Scienture’s assets in exchange f...
2024-07-26 22:47
Trxade Group declares $1.50 special dividend
Trxade Group (NASDAQ:MEDS) declares $1.50/share special dividend. Payable July 24; for shareholders of record July 19; ex-div July 19. See MEDS Dividend Scorecard, Yield Chart, & Dividend Growth. More...
2024-07-09 20:06
TRxADE HEALTH shares are trading higher. The company reported Q1 financial results.
TRxADE HEALTH shares are trading higher. The company reported Q1 financial resu...
2024-06-27 20:15
Trxade Health Q1 EPS $(6.40) Down From $(0.45) YoY
Trxade Health (NASDAQ:MEDS) reported quarterly losses of $(6.40) per share. This is a 1322.22 percent decrease over losses of $(0.45) per share from the same period last year.
2024-06-27 20:03
